Markets.com Logo

IMV

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    5.8717$
  • Previous Close
    5.8717$
  • 52 Week Change
    3.15$
  • Day Range
    0.00$
  • 52 Week High/Low
    5.8$ - 8.9545$
  • Dividend Per Share
    0.0277
  • Market cap
    192 M$
  • EPS
    0.23
  • Beta
    1.385
  • Volume
    --

About

IMV.F is the ticker symbol for IMV Inc. traded on the Frankfurt Stock Exchange (FSE). IMV Inc. is a clinical-stage biopharmaceutical company focused on developing a novel class of immunotherapies based on its proprietary DPX platform. This technology is designed to program immune cells to fight cancer and infectious diseases. The Frankfurt Stock Exchange listing allows European investors to trade shares of IMV Inc., providing broader access to the company's stock beyond its primary listing.

Gold's Safe-Haven Status Under Scrutiny: Market Dynamics and Price Outlook

Emma Rose|--

Trump's Iran War Exit Without a Deal: Reshaping Middle East Energy Security and Power Dynamics

Emma Rose|--
European market insights: What is the European stock market doing right now?

European market insights: What is the European stock market doing right now?

Ghko B|--
EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

Ghko B|--

Microsoft at a Crossroads: AI Hurdles and Cloud Resilience Amidst Market Volatility

Sophia Claire|--

Iran's Hormuz Gambit: Leveraging a Chokepoint for Economic Leverage and Global Impact

Ava Grace|--

Gold Market Resilience: Navigating Sell-offs and Sustaining Bull Run

Noah Lee|--

Factors

Company-Specific News: Positive or negative announcements regarding IMV's research, clinical trial results, or partnerships directly influence investor sentiment and stock price.

Overall Market Conditions: Broad market trends, economic health, and investor risk appetite impact almost all stocks, including IMV.F.

Industry Trends: Developments in the immunotherapy sector, competitive landscape, and regulatory changes affecting cancer treatments can shift investor perception of IMV's potential.

Financial Performance: IMV's cash position, burn rate, and ability to secure funding influence investor confidence in the company's long-term viability.

Investor Sentiment: Social media buzz, online forums, and overall market hype can drive short-term fluctuations in stock price, regardless of fundamental value.

Regulatory Approvals: Progress toward regulatory approval for IMV's products greatly impacts the company's perceived value and investor enthusiasm.

Competition: The success or failure of competing therapies and companies can affect the perceived value and market share potential of IMV.F.

People Also Watch

Latest news

US Steel and Aluminum Tariffs Revamped: Simplification Amidst Potential Cost Increases

Noah Lee|--

SpaceX Files Secret IPO Bid, Eyeing Record-Breaking $1.75 Trillion Valuation

Ava Grace|--

US Intelligence: Iran Unwilling to Engage in Substantive Talks to End War

Sophia Claire|--

Latest Education Articles

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

Ghko B|--
Investing basics for beginners: What are the 4 economic indicators?

Investing basics for beginners: What are the 4 economic indicators?

Frances Wang|--
CFDs vs Options: What’s the Difference?

CFDs vs Options: What’s the Difference?

Julian Parker|--